Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The ten-eleven translocation (TET) family of methylcytosine dioxygenases initiates demethylation of DNA and is associated with tumorigenesis in many cancers; however, the mechanism is mostly unknown. Here we identify upstream activators and downstream effectors of TET1 in breast cancer using human breast cancer cells and a genetically engineered mouse model. We show that depleting the architectural transcription factor high mobility group AT-hook 2 (HMGA2) induces TET1. TET1 binds and demethylates its own promoter and the promoter of homeobox A (HOXA) genes, enhancing its own expression and stimulating expression of HOXA genes including HOXA7 and HOXA9. Both TET1 and HOXA9 suppress breast tumor growth and metastasis in mouse xenografts. The genes comprising the HMGA2-TET1-HOXA9 pathway are coordinately regulated in breast cancer and together encompass a prognostic signature for patient survival. These results implicate the HMGA2-TET1-HOX signaling pathway in the epigenetic regulation of human breast cancer and highlight the importance of targeting methylation in specific subpopulations as a potential therapeutic strategy.

Original publication

DOI

10.1073/pnas.1305172110

Type

Journal article

Journal

Proc Natl Acad Sci U S A

Publication Date

11/06/2013

Volume

110

Pages

9920 - 9925

Keywords

Animals, Breast Neoplasms, Cell Line, Tumor, DNA-Binding Proteins, Female, Gene Expression Profiling, HMGA2 Protein, Homeodomain Proteins, Humans, Immunoblotting, Kaplan-Meier Estimate, Male, Mammary Neoplasms, Experimental, Mice, Mice, Inbred C57BL, Mice, Knockout, Mice, Transgenic, Mixed Function Oxygenases, Neoplasm Metastasis, Oligonucleotide Array Sequence Analysis, Prognosis, Proto-Oncogene Proteins, RNA Interference, Reverse Transcriptase Polymerase Chain Reaction, Signal Transduction, Transplantation, Heterologous, Wnt1 Protein